Cannabix Technologies, Inc is a unique company among the marijuana businesses that aim to fill the various needs of the industry. While there are research firms, cultivators, dispensaries, and marketers, Cannabix Technologies offers technology and a unique solution: a law enforcement tool called the Marijuana Breathalyzer.
The company started a couple of years before marijuana legitimization made the front pages in North American news. In 2011, the company was founded as West Point Resources, Inc. it started developing the cannabis breathalyzer tool under the brand name Cannabix. Then, in August 2014, at the height of the “green rush”, it changed its company name to Cannabix Technologies, Inc.
Currently, Cannabix Technologies is listed in the Canadian Securities Exchange as BLO, as well as in the US OTC markets as BLOZF. The company is valued at USD 7.4 M.
The Cannabix Marijuana Breathalyzer is its prime product. It is a drug-impairment recognition device that is similar to the alcohol breathalyzer currently used by authorities. Both tools test and analyze breath samples, but instead of alcohol levels, the Marijuana Breathalyzer detects tetrahydrocannabinol (THC), a psychoactive compound of marijuana.
Cannabix Technologies now markets this device as a tool to stop marijuana-intoxicated drivers. In addition, it can be used to inhibit THC-intoxicated employees where such intoxication could be considered a workplace hazard.
According to the company, the technology used in the Cannabix Marijuana Breathalyzer was sparked by a Swedish study on the same subject. It was then picked up by Cannabix President Kal Malhi, who formerly served in the Royal Canadian Mounted Police.
Aside from Malhi, top executives at Cannabix Technologies include CEO Rav Mlait, Chief Engineer Dr. Raj Attariwala, Senior Advisor Bruce Goldberger, and CFO Bryan Loree.
Yahoo! Finance: BLOZF News
Latest Financial News for BLOZF
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace, is pleased to report that the Company has developed a new version of its THC Breath Analyzer (“THCBA”) and is preparing for additional testing with the device. Company engineers have updated several components in the THCBA and have changed the form factor for improved handling. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ∆9-tetrahydrocannabinol (“THC”) - the psychoactive component of marijuana that causes impairment.
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”), developer of marijuana breathalyzer devices for law enforcement and the workplace, reports that the Company and its staff remain operational at our labs in Vancouver, B.C. and Gainesville, Florida. The Company is closely monitoring the COVID-19 pandemic and has implemented additional measures at its lab locations to help safeguard the health of its staff while continuing to operate effectively. The Company has also begun preparations if further measures are implemented by governments in the coming days and weeks ahead.
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company” or “Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports that a significant technological development has been achieved with its FAIMS- (field asymmetric waveform ion mobility spectrometry) marijuana breathalyzer prototype. Cannabix scientists have been characterizing the device for several months to increase resolving power and sensitivity. The Company is pleased to report that the Beta 3.1 FAIMS device has achieved ion-resolving levels that enable the isolation of ∆9-tetrahydrocannabinol (“THC”) in human breath and suppress background compounds effectively.
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace is pleased to report that Dr. Moe Paknahad has joined the Company as VP of Technology Development. Dr. Paknahad will help direct product development of Cannabix’s THC breathalyzer devices.
Seattle, Washington--(Newsfile Corp. - January 13, 2020) - CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing the latest technology in cannabis breathalyzers.Cannabix LogoTo view an enhanced version of this graphic, please visit:https://orders.newsfilecorp.com/files/5503/51368_137f3af9f4c4caaf_001full.jpgAs many states have legalized marijuana in some form, the safety concerns surrounding cannabis-impaired driving are growing. According to the US Centers for Disease Control and Prevention, ...